메뉴 건너뛰기




Volumn 7, Issue 3, 2012, Pages

Csf concentrations of camp and cgmp are lower in patients with creutzfeldt-jakob disease but not parkinson's disease and amyotrophic lateral sclerosis

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIC AMP; CYCLIC GMP; TAU PROTEIN;

EID: 84857741089     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032664     Document Type: Article
Times cited : (22)

References (47)
  • 1
    • 0036729478 scopus 로고    scopus 로고
    • Cyclic nucleotide research - still expanding after half a century
    • Beavo JA, Brunton LL, (2002) Cyclic nucleotide research - still expanding after half a century. Nat Rev Mol Cell Biol 3: 710-718.
    • (2002) Nat Rev Mol Cell Biol , vol.3 , pp. 710-718
    • Beavo, J.A.1    Brunton, L.L.2
  • 2
    • 56349152612 scopus 로고    scopus 로고
    • Regulation and function of cyclic GMP-mediated pathways in glial cells
    • Baltrons MA, Boran MS, Pifarre P, Garcia A, (2008) Regulation and function of cyclic GMP-mediated pathways in glial cells. Neurochem Res 33: 2427-2435.
    • (2008) Neurochem Res , vol.33 , pp. 2427-2435
    • Baltrons, M.A.1    Boran, M.S.2    Pifarre, P.3    Garcia, A.4
  • 3
    • 77955089959 scopus 로고    scopus 로고
    • CXCR4-mediated glutamate exocytosis from astrocytes
    • Cali C, Bezzi P, (2010) CXCR4-mediated glutamate exocytosis from astrocytes. J Neuroimmunol 224: 13-21.
    • (2010) J Neuroimmunol , vol.224 , pp. 13-21
    • Cali, C.1    Bezzi, P.2
  • 4
    • 50449099017 scopus 로고    scopus 로고
    • Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms
    • Giorgi M, D'Angelo V, Esposito Z, Nuccetelli V, Sorge R, et al. (2008) Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. Eur J Neurosci 28: 941-950.
    • (2008) Eur J Neurosci , vol.28 , pp. 941-950
    • Giorgi, M.1    D'Angelo, V.2    Esposito, Z.3    Nuccetelli, V.4    Sorge, R.5
  • 5
    • 0027742932 scopus 로고
    • Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease
    • Hossain MA, Weiner N, (1993) Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease. J Pharmacol Exp Ther 267: 1105-1111.
    • (1993) J Pharmacol Exp Ther , vol.267 , pp. 1105-1111
    • Hossain, M.A.1    Weiner, N.2
  • 6
    • 0033573697 scopus 로고    scopus 로고
    • Degeneration of NO-synthesizing cerebrocortical neurons in transgenic mice expressing mutated superoxide dismutase is not due to elevated nitric oxide levels
    • Aguila MC, Kuljis RO, (1999) Degeneration of NO-synthesizing cerebrocortical neurons in transgenic mice expressing mutated superoxide dismutase is not due to elevated nitric oxide levels. Brain Res 816: 241-244.
    • (1999) Brain Res , vol.816 , pp. 241-244
    • Aguila, M.C.1    Kuljis, R.O.2
  • 7
    • 0035978743 scopus 로고    scopus 로고
    • Amyotrophic lateral sclerosis
    • Rowland LP, Shneider NA, (2001) Amyotrophic lateral sclerosis. N Engl J Med 344: 1688-1700.
    • (2001) N Engl J Med , vol.344 , pp. 1688-1700
    • Rowland, L.P.1    Shneider, N.A.2
  • 8
    • 9744227184 scopus 로고    scopus 로고
    • Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains
    • Baltrons MA, Pifarre P, Ferrer I, Carot JM, Garcia A, (2004) Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains. Neurobiol Dis 17: 462-472.
    • (2004) Neurobiol Dis , vol.17 , pp. 462-472
    • Baltrons, M.A.1    Pifarre, P.2    Ferrer, I.3    Carot, J.M.4    Garcia, A.5
  • 11
    • 0035100888 scopus 로고    scopus 로고
    • Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
    • Biomarkers Definitions Working Group
    • Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69: 89-95.
    • (2001) Clin Pharmacol Ther , vol.69 , pp. 89-95
  • 13
    • 77958065565 scopus 로고    scopus 로고
    • Problems associated with fluid biomarkers for Parkinson's disease
    • Nyhlen J, Constantinescu R, Zetterberg H, (2010) Problems associated with fluid biomarkers for Parkinson's disease. Biomark Med 4: 671-681.
    • (2010) Biomark Med , vol.4 , pp. 671-681
    • Nyhlen, J.1    Constantinescu, R.2    Zetterberg, H.3
  • 14
    • 65549111767 scopus 로고    scopus 로고
    • Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review
    • Jesse S, Steinacker P, Lehnert S, Gillardon F, Hengerer B, et al. (2009) Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review. CNS Neurosci Ther 15: 157-182.
    • (2009) CNS Neurosci Ther , vol.15 , pp. 157-182
    • Jesse, S.1    Steinacker, P.2    Lehnert, S.3    Gillardon, F.4    Hengerer, B.5
  • 15
    • 79951720856 scopus 로고    scopus 로고
    • alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
    • Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, et al. (2011) alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10: 230-240.
    • (2011) Lancet Neurol , vol.10 , pp. 230-240
    • Mollenhauer, B.1    Locascio, J.J.2    Schulz-Schaeffer, W.3    Sixel-Doring, F.4    Trenkwalder, C.5
  • 19
    • 0037709838 scopus 로고    scopus 로고
    • Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease
    • Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, et al. (2003) Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 60: 813-816.
    • (2003) Arch Neurol , vol.60 , pp. 813-816
    • Geschwind, M.D.1    Martindale, J.2    Miller, D.3    DeArmond, S.J.4    Uyehara-Lock, J.5
  • 20
    • 0037154135 scopus 로고    scopus 로고
    • Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
    • Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, et al. (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58: 192-197.
    • (2002) Neurology , vol.58 , pp. 192-197
    • Otto, M.1    Wiltfang, J.2    Cepek, L.3    Neumann, M.4    Mollenhauer, B.5
  • 21
    • 78650671552 scopus 로고    scopus 로고
    • ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients
    • Steinacker P, Klafki H, Lehnert S, Jesse S, Arnim CA, et al. (2010) ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients. J Alzheimers Dis 22: 119-128.
    • (2010) J Alzheimers Dis , vol.22 , pp. 119-128
    • Steinacker, P.1    Klafki, H.2    Lehnert, S.3    Jesse, S.4    Arnim, C.A.5
  • 22
    • 73549105915 scopus 로고    scopus 로고
    • Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease
    • Steinacker P, Rist W, Swiatek-de-Lange M, Lehnert S, Jesse S, et al. (2010) Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease. Proteomics 10: 81-89.
    • (2010) Proteomics , vol.10 , pp. 81-89
    • Steinacker, P.1    Rist, W.2    Swiatek-de-Lange, M.3    Lehnert, S.4    Jesse, S.5
  • 23
    • 79751535822 scopus 로고    scopus 로고
    • Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion
    • Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, et al. (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17: 175-178.
    • (2011) Nat Med , vol.17 , pp. 175-178
    • Atarashi, R.1    Satoh, K.2    Sano, K.3    Fuse, T.4    Yamaguchi, N.5
  • 24
    • 36649029701 scopus 로고    scopus 로고
    • Peirce, Youden, and Receiver Operating Characteristic Curves
    • Baker SG, Kramer BS, (2007) Peirce, Youden, and Receiver Operating Characteristic Curves. Am Stat 61: 343-346.
    • (2007) Am Stat , vol.61 , pp. 343-346
    • Baker, S.G.1    Kramer, B.S.2
  • 25
    • 10744219944 scopus 로고    scopus 로고
    • Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study
    • Otto M, Cepek L, Ratzka P, Doehlinger S, Boekhoff I, et al. (2004) Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study. Neurology 62: 714-718.
    • (2004) Neurology , vol.62 , pp. 714-718
    • Otto, M.1    Cepek, L.2    Ratzka, P.3    Doehlinger, S.4    Boekhoff, I.5
  • 26
    • 0006164301 scopus 로고    scopus 로고
    • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop
    • McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124.
    • (1996) Neurology , vol.47 , pp. 1113-1124
    • McKeith, I.G.1    Galasko, D.2    Kosaka, K.3    Perry, E.K.4    Dickson, D.W.5
  • 27
    • 82055185503 scopus 로고    scopus 로고
    • Simultaneous LC-MS/MS analysis of the biomarkers cAMP and cGMP in plasma, CSF and brain tissue
    • Oeckl P, Ferger B, (2011) Simultaneous LC-MS/MS analysis of the biomarkers cAMP and cGMP in plasma, CSF and brain tissue. J Neurosci Methods 203: 338-343.
    • (2011) J Neurosci Methods , vol.203 , pp. 338-343
    • Oeckl, P.1    Ferger, B.2
  • 29
    • 0021309291 scopus 로고
    • Analysis of neurotransmitter metabolites and adenosine 3′,5′-monophosphate in the CSF of patients with extrapyramidal motor disorders
    • Cramer H, Warter JM, Renaud B, (1984) Analysis of neurotransmitter metabolites and adenosine 3′,5′-monophosphate in the CSF of patients with extrapyramidal motor disorders. Adv Neurol 40: 431-435.
    • (1984) Adv Neurol , vol.40 , pp. 431-435
    • Cramer, H.1    Warter, J.M.2    Renaud, B.3
  • 30
    • 0029003713 scopus 로고
    • Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases
    • Ikeda M, Sato I, Yuasa T, Miyatake T, Murota S, (1995) Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases. J Neural Transm Gen Sect 100: 263-267.
    • (1995) J Neural Transm Gen Sect , vol.100 , pp. 263-267
    • Ikeda, M.1    Sato, I.2    Yuasa, T.3    Miyatake, T.4    Murota, S.5
  • 31
    • 0019476341 scopus 로고
    • Cyclic adenosine 3′,5′ monophosphate in cerebrospinal fluid of multiple sclerosis patients
    • Maida E, Kristoferitsch W, (1981) Cyclic adenosine 3′,5′ monophosphate in cerebrospinal fluid of multiple sclerosis patients. J Neurol 225: 145-151.
    • (1981) J Neurol , vol.225 , pp. 145-151
    • Maida, E.1    Kristoferitsch, W.2
  • 33
    • 0015698643 scopus 로고
    • Adenosine 3′,5′-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease
    • Cramer H, Ng LK, Chase TN, (1973) Adenosine 3′,5′-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease. Arch Neurol 29: 197-199.
    • (1973) Arch Neurol , vol.29 , pp. 197-199
    • Cramer, H.1    Ng, L.K.2    Chase, T.N.3
  • 34
    • 58949095596 scopus 로고    scopus 로고
    • Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3′,5′-monophosphate (cGMP) in clinical applications: a comparison with a EIA method
    • Zhang Y, Dufield D, Klover J, Li W, Szekely-Klepser G, et al. (2009) Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3′,5′-monophosphate (cGMP) in clinical applications: a comparison with a EIA method. J Chromatogr B Analyt Technol Biomed Life Sci 877: 513-520.
    • (2009) J Chromatogr B Analyt Technol Biomed Life Sci , vol.877 , pp. 513-520
    • Zhang, Y.1    Dufield, D.2    Klover, J.3    Li, W.4    Szekely-Klepser, G.5
  • 35
    • 0345055825 scopus 로고    scopus 로고
    • Cerebrospinal fluid cyclic guanosine 3′5′ monophosphate levels in Parkinson's disease
    • Navarro JA, Jimenez-Jimenez FJ, Molina JA, ito-Leon J, Cisneros E, et al. (1998) Cerebrospinal fluid cyclic guanosine 3′5′ monophosphate levels in Parkinson's disease. J Neurol Sci 155: 92-94.
    • (1998) J Neurol Sci , vol.155 , pp. 92-94
    • Navarro, J.A.1    Jimenez-Jimenez, F.J.2    Molina, J.A.3    ito-Leon, J.4    Cisneros, E.5
  • 38
    • 76749084276 scopus 로고    scopus 로고
    • Selective D1 agonism but not D2 antagonism is reflected in cAMP and cGMP levels in rat CSF
    • Torremans A, Van HA, Straetemans R, Vanhoof G, Van Den KG, et al. (2010) Selective D1 agonism but not D2 antagonism is reflected in cAMP and cGMP levels in rat CSF. Brain Res Bull 81: 549-551.
    • (2010) Brain Res Bull , vol.81 , pp. 549-551
    • Torremans, A.1    van, H.A.2    Straetemans, R.3    Vanhoof, G.4    van Den, K.G.5
  • 39
    • 0344994681 scopus 로고    scopus 로고
    • Increased cerebrospinal fluid cAMP levels in Alzheimer's disease
    • Martinez M, Fernandez E, Frank A, Guaza C, de la FM, et al. (1999) Increased cerebrospinal fluid cAMP levels in Alzheimer's disease. Brain Res 846: 265-267.
    • (1999) Brain Res , vol.846 , pp. 265-267
    • Martinez, M.1    Fernandez, E.2    Frank, A.3    Guaza, C.4    de la, F.M.5
  • 40
    • 0019455113 scopus 로고
    • CSF Vasopressin and cyclic nucleotide concentrations in senile dementia
    • Tsuji M, Takahashi S, Akazawa S, (1981) CSF Vasopressin and cyclic nucleotide concentrations in senile dementia. Psychoneuroendocrinology 6: 171-176.
    • (1981) Psychoneuroendocrinology , vol.6 , pp. 171-176
    • Tsuji, M.1    Takahashi, S.2    Akazawa, S.3
  • 41
    • 0022376119 scopus 로고
    • Catecholamine metabolites and cyclic nucleotides in cerebrospinal fluid in dementia of Alzheimer type
    • Volicer L, Direnfeld LK, Langlais PJ, Freedman M, Bird ED, et al. (1985) Catecholamine metabolites and cyclic nucleotides in cerebrospinal fluid in dementia of Alzheimer type. J Gerontol 40: 708-713.
    • (1985) J Gerontol , vol.40 , pp. 708-713
    • Volicer, L.1    Direnfeld, L.K.2    Langlais, P.J.3    Freedman, M.4    Bird, E.D.5
  • 42
    • 10744228025 scopus 로고    scopus 로고
    • Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis
    • Ilzecka J, (2004) Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis. J Neural Transm 111: 167-172.
    • (2004) J Neural Transm , vol.111 , pp. 167-172
    • Ilzecka, J.1
  • 43
    • 77953340215 scopus 로고    scopus 로고
    • Prion diseases
    • Venneti S, (2010) Prion diseases. Clin Lab Med 30: 293-309.
    • (2010) Clin Lab Med , vol.30 , pp. 293-309
    • Venneti, S.1
  • 45
    • 0033849497 scopus 로고    scopus 로고
    • An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients
    • Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, et al. (2000) An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol 48: 395-398.
    • (2000) Ann Neurol , vol.48 , pp. 395-398
    • Kenney, K.1    Brechtel, C.2    Takahashi, H.3    Kurohara, K.4    Anderson, P.5
  • 46
    • 9844234269 scopus 로고    scopus 로고
    • S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
    • Otto M, Stein H, Szudra A, Zerr I, Bodemer, et al. (1997) S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 244: 566-570.
    • (1997) J Neurol , vol.244 , pp. 566-570
    • Otto, M.1    Stein, H.2    Szudra, A.3    Zerr, I.4    Bodemer5
  • 47
    • 79952400329 scopus 로고    scopus 로고
    • Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders
    • Singh A, Beveridge AJ, Singh N, (2011) Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders. PLoS One 6: e16804.
    • (2011) PLoS One , vol.6
    • Singh, A.1    Beveridge, A.J.2    Singh, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.